SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-24-033858
Filing Date
2024-02-13
Accepted
2024-02-13 16:43:58
Documents
2
Group Members
JULIET TAMMENOMS BAKKERLONGITUDE VENTURE PARTNERS IV, L.P.PATRICK G. ENRIGHT

Document Format Files

Seq Description Document Type Size
1 SC 13G d650822dsc13g.htm SC 13G 81994
2 EX-99.1 d650822dex991.htm EX-99.1 6093
  Complete submission text file 0001193125-24-033858.txt   89814
Mailing Address 2740 SAND HILL ROAD 2ND FLOOR MENLO PARK CA 94025
Business Address 2740 SAND HILL ROAD 2ND FLOOR MENLO PARK CA 94025 650-854-5700
Longitude Capital Partners IV, LLC (Filed by) CIK: 0001829169 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Subject) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94231 | Film No.: 24626874
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)